Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Company's lead programs are ABO-101 (AA9 NAGLU) and ABO-102 (scAAV9 SGHG), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (Mucopolysaccharidosis (MPS) IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. The Company is also developing ABO-201 (scAAV9 CLN3) gene therapy for juvenile Batten disease (JBD), and ABO-301 (AAV LK19 FANCC) for Fanconi anemia (FA) disorder using a clustered, regularly interspaced short palindromic repeats (CRISPR)/Cas9-based gene editing approach to gene therapy program for rare blood diseases. It is developing rare plasma protein therapies, including PTB-101 SDF Alpha (alpha-1 protease inhibitor) for inherited chronic obstructive pulmonary disease. Its product pipeline also consists of MuGard and ProdiGard.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCMKTS:ACCP
- CUSIP: N/A
- Web: N/A
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
Frequently Asked Questions for Abeona Therapeutics (OTCMKTS:ACCP)
What is Abeona Therapeutics' stock symbol?
Abeona Therapeutics trades on the OTCMKTS under the ticker symbol "ACCP."
Who are some of Abeona Therapeutics' key competitors?
Some companies that are related to Abeona Therapeutics include Merck KGaA (MKGAY), Hospira (HSP), Omnicare (OCR), Health Net (HNT), WuXi PharmaTech (Cayman) (WX), Hanger (HGR), SIGA Technologies (SIGA), Nobilis Health Corp (HLTH), Verastem (VSTM), Palatin Technologies (PTN), KaloBios Pharmaceuticals (KBIO), AdCare Health Systems (ADK), Capricor Therapeutics (CAPR), 3SBio (SSRX), Alexza Pharmaceuticals (ALXA), Allergan plc (WPI), Allergan plc (ACT) and Allos Therapeutics (ALTH).
Who are Abeona Therapeutics' key executives?
Abeona Therapeutics' management team includes the folowing people:
- Steven H Rouhandeh, Executive Chairman of the Board
- Timothy J Miller Ph.D., President, Chief Executive Officer, Director
- Harrison G Wehner III, Chief Financial Officer
- Jeffrey B. Davis, Chief Operating Officer, Director
- Stephen B. Thompson, Chief Accounting Officer, Vice President - Finance, Treasurer, Secretary
- Todd Wider M.D., Director
- Mark J. Alvino, Independent Director
- Stephen B. Howell M.D., Independent Director
How do I buy Abeona Therapeutics stock?
Shares of Abeona Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Abeona Therapeutics stock cost?
One share of Abeona Therapeutics stock can currently be purchased for approximately $0.22.
Consensus Ratings for Abeona Therapeutics (OTCMKTS:ACCP) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Abeona Therapeutics (OTCMKTS:ACCP)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Abeona Therapeutics (OTCMKTS:ACCP)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Abeona Therapeutics (OTCMKTS:ACCP)
Current Year EPS Consensus Estimate: $0.70 EPS
Dividend History for Abeona Therapeutics (OTCMKTS:ACCP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Abeona Therapeutics (OTCMKTS:ACCP)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Abeona Therapeutics (OTCMKTS:ACCP)
Latest Headlines for Abeona Therapeutics (OTCMKTS:ACCP)
Abeona Therapeutics (ACCP) Chart for Monday, May, 29, 2017